Literature DB >> 8263560

Probable exacerbation of myasthenia gravis by ofloxacin.

E Azevedo, J A Ribeiro, J Polónia, C Pontes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8263560     DOI： 10.1007/bf00874123

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Ciprofloxacin and myasthenia gravis.

Authors:  C J Mumford; L Ginsberg
Journal:  BMJ       Date:  1990-10-06

2.  Comment: Myasthenia gravis and ciprofloxacin.

Authors:  D S Maddix; A Stefani
Journal:  Ann Pharmacother       Date:  1992-02       Impact factor: 3.154

3.  Exacerbation of myasthenia gravis by norfloxacin.

Authors:  E H Rauser; R E Ariano; B A Anderson
Journal:  DICP       Date:  1990-02

4.  Possible exacerbation of myasthenia gravis by ciprofloxacin.

Authors:  B Moore; M Safani; J Keesey
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

5.  Toward the operational identification of adverse drug reactions.

Authors:  F E Karch; L Lasagna
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

Review 6.  Drug-induced myasthenic syndromes.

Authors:  H E Kaeser
Journal:  Acta Neurol Scand Suppl       Date:  1984
  6 in total
  2 in total

Review 1.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 2.  Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Authors:  S Christopher Jones; Alfred Sorbello; Robert M Boucher
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.